Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism

Annals of Hematology

Volumn 84, Issue 10, 2005, Pages 650-655

  Gómez Llorente, Carolina ^a   Miranda Leó, M Teresa ^a   Blanco, Sonia ^a   Gandia Pla, Sandra ^b   Gómez Capilla, Jose Antonio ^a,b   Fárez Vidal, M Esther ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Ferritin; Haemochromatosis; HFE mutations; Iron; Transferrin saturation

Indexed keywords

FERRITIN; HFE PROTEIN;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON METABOLISM; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SPAIN; STATISTICAL SIGNIFICANCE;

AMINO ACID SUBSTITUTION; FEMALE; FERRITINS; GENE EXPRESSION; GENE FREQUENCY; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; POINT MUTATION; SPAIN;

EID: 27644545822     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1069-6     Document Type: Article

References (48)

1. Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S (2000) Population screening for hemochromatosis: A comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5211 voluntary blood donors. Hepatology 31:1160-1164
2. Alvarez S, Mesa MS, Bandres F, Arroyo E (2001) C282Y and H63D mutation frequencies in a population from central Spain. Dis Markers 17:111-114
3. Altes A, Ruiz A, Barcelo MJ et al (2004) Prevalence of the C282Y, H63D, and S65C mutations of the HFE gene in 1,146 newborns from a region of northern Spain. Genet Test 8:407-410
4. Andrews NC, Levy JE (1998) Iron is hot: An update on the pathophysiology of hemochromatosis. Blood 92:1845-1851
5. Asberg A, Hveem K, Thorstensen K et al (2001) Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 36:1108-1115
6. Baiget M, Barcelo MJ, Gimferrer E (1998) Frequency of the HFE C282Y and H63D mutations in distinct ethnic groups living in Spain. J Med Genet 35:701
7. Barton JC, Sawada-Hirai R, Rothenberg BE et al (1999) Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis 5:146-154
8. Bauduer F, Scribans C, Degioanni A et al (2005) Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque country. Ann Hematol 84:99-102
9. Beutler E, Gelbart T, West C et al (1996) Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 22:187-194
10. Beutler E (1997) Genetic iron beyond haemochromatosis: Clinical effects of HLA-H mutations. Lancet 349:296-297
11. Beutler E (1997) The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 61:762
12. Beutler E, Felitti VJ, Koziol JA et al (2002) Penetrance of the 845G6A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 3059:211-218
13. Beutler E, Griffin MJ, Gelbart T et al (2002) A previously undescribed nonsense mutation of the HFE gene. Clin Genet 61:40-42
14. Borot N, Roth MP, Malfroy L et al (1997) Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 45:320
15. Bothwell TH, MacPhail AP (1998) Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Semin Hematol 35:55-71
16. Bulaj ZJ, Griffen LM, Jorde LB et al (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-1805
17. Burt MJ, George PM, Upton JD et al (1998) The significance of haemochromatosis gene mutations in the general population: Implications for screening. Gut 43:830-836
18. Carella M, D'Ambrosio L, Totaro A et al (1997) Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 60:828
19. Cassanelli S, Pignatti E, Montosi G et al (2001) Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol 34:523-528
20. Fabrega E, Castro B, Sanchez-Castro L et al (1999) The prevalence of the Cys282Tyr mutation in the hemochromatosis gene in Cantabria in patients diagnosed with hereditary hemochromatosis. Med Clin 112:451-453 (Barc)
21. Feder JN, Gnirke A, Thomas W et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
22. Feder JN, Tsuchihashi Z, Irrinki A et al (1997) The hemochromatosis founder mutation in HLA-H disrupts b2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025
23. Feder JN, Penny DM, Irrinki A et al (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 95:1472
24. Gomez-Llorente C, Antunez A, Blanco S et al (2004) Multiplex analysis of the most common mutations related to hereditary haemochromatosis: Two methods combining specific amplification with capillary electophoresis. Eur J Haematol 72:121-129
25. Gottschalk R, Seidl C, Schilling S et al (2000) Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferring receptor Hin6I and BanI polymorphism in German patients with hereditary haemochromatosis. Eur J Inmunogenet 27:129-134 10.1046/ j.1365-2370.2000.00215.x
26. Guix P, Picornell A, Parera, Tomas C et al (2000) Prevalence of the C282Y mutation for haemochromatosis on the Island of Majorca. Clin Genet 58:123-128 123-128 10.1034/j.1399-0004.2000.580206.x
27. Jackson HA, Caster K, Darke C et al (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:47-484 10.1046/j.1365-2141.2001.02949.x
28. Jazwinska EC, Cullen LM, Busfield F et al (1996) Haemochromatosis and HLA-H. Nat Genet 14:249 10.1038/ng1196-249
29. Jouanolle AM, Gandon G, Jezequel P et al (1996) Haemochromatosis and HLA-H. Nat Genet 14:251 10.1038/ng1196-251
30. McLaren CE, McLachlan GJ, Halliday JW et al (1998) Distribution of transferrin saturation in an Australian population: Relevance to the early diagnosis of hemochromatosis. Gastroenterology 114:543-549 1:STN:280:DyaK1c7ls1Klsg%3D%3D
31. Merryweather-Clarke AT, Pointon JJ, Shearman JD et al (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275-278 1:STN:280:ByiB1cvgslY%3D
32. Merryweather-Clarke AT, Worwood M, Parkinson L et al (1998) The effect of HFE mutations on serum ferritin and transferring saturation in the Jersey population. Br J Haematol 101:369-373 10.1046/ j.1365-2141.1998.00736.x
33. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM et al (2000) Geography of HFE C282Y and H63D mutations. Genetic Test 4:183-198 10.1089/ 10906570050114902
34. Moirand R, Guyader D, Mendler MH et al (2002) Based re-evaluation of heterozygous hemochromatosis. Am J Med Genet 111:356-361
35. Mura C, Nousbaum JB, Verger P et al (1997) Phenotype-genotype correlation in hemochromatosis patients. Hum Genet 101:271 10.1007/ s004390050628
36. Mura C, Ragueness O, Ferec C et al (1999) HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502-2505 1:CAS:528:DyaK1MXisVGktrk%3D
37. Nichols GM, Bacon BR (1989) Hereditary hemochromatosis: Pathogenesis and clinical features of a common disease. Am J Gastroenterol 84:851-862 1:STN:280:BiaA3szmtl0%3D
38. Milman N, Steig T, Koefoed P et al (2005) Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands. Ann Hematol 84:146-149 10.1007/s00277-004-0865-8
39. Milman N, Pedersen P, Ovesen L et al (2004) Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol 83:654-657 10.1007/s00277-004-0874-7
40. Olynyk JK, Cullen DJ, Aquilia S et al (1999) Population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718-724
41. Pardo A, Quintero E, Barrios Y et al (2004) Genotype and phenotypic expression of hereditary hemochromatosis in Spain. Gastroenterol Hepatol 27:437-443 10.1157/13065947
42. Pietrangelo A, Camaschella C (1998) Molecular genetics and control of iron metabolism in hemochromatosis. Haematologica 83:456-461 1:CAS:528:DyaK1cXlsFehsLY%3D
43. Piperno A, Sampietro M, Pietrangelo A et al (1998) Heterogeneity of hemochromatosis in Italy. Gastroenterology 114:9960-1002 1:STN:280:DyaK1c3isFWgsw%3D%3D
44. Porto G, Alves H, Rodrigues P et al (1998) Major histocompatibility complex class I associations in iron overload: Evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis. Immunogenetics 47:404-410 10.1007/s002510050376
45. Powell LW, Summers KM, Board PG et al (1990) Expression of hemochromatosis in homozygous subjects: Implications for early diagnosis and prevention. Gastroenterology 98:1625-1632 1:STN:280:By%2BB2cbmsFw%3D
46. Sanchez M, Bruguera M, Bosch J et al (1998) Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 29:725-728 10.1016/ S0168-8278(98)80252-3
47. Sanchez M, Bruguera M, Quintero E et al (2000) Hereditary hemochromatosis in Spain. Genet Test 4:171-176 10.1089/10906570050114885
48. Sanchez M, Villa M, Ingelmo M et al (2003) Population screening for hemochromatosis: A study in 5370 Spanish blood donors. J Hepatol 38:745-750 10.1016/S0168-8278(03)00123-5